The American Journal of Medicine
Volume 123, Issue 4 , Pages 317-319 , April 2010

A Blistering Rash

  • Adetunji A. Adejumo, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Adetunji A. Adejumo, MD, Columbia University/Harlem Hospital Center, Department of Infectious Disease, 506 Lenox Avenue, New York, NY 10037
    • ,
  • Sharon B. Mannheimer, MD

References 

  1. Bygum A, Christiansen L, Petersen NE, et al. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol. 2003;83:115–120
  2. Disler P, Day B, Blekkenhorst G, Eales L. Photosensitivity in erythropoietic protoporphyria and porphyria cutanea tarda. NEJM. 1981;304:1363–1364
  3. Elder GH, Smith SG, Herrero C, et al. Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?. Lancet. 1981;1:916–919
  4. Moran-Jimenez MJ, Ged C, Romana M, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet. 1996;58:712–721
  5. Hussain I, Hepburn NC, Jones A, et al. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin and Experim Dermatol. 1996;21:283–285
  6. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992;16:1322–1326
  7. Puchner KP, Berg T. Extrahepatic manifestations of chronic hepatitis C virus infection. Z Gastroenterol. 2009;47:446–456
  8. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci. 2003;325:135–148
  9. Medina J, Garcia-Buey L, Moreno-Otero R. Hepatitis C virus-related extra-hepatic disease—aetiopathogenesis and management. Aliment Pharmacol Ther. 2004;20:129–141
  10. Fritsch C, Lang K, von Schmiedeberg S, et al. Porphyria cutanea tarda. Skin Pharmcol Appl Skin Physiol. 1998;11:321–335
  11. Petersen CS, Thomsen K. High-dose hydroxychloroquine treatment of porphyria cutanea tarda. J Am Acad Dermatol. 1992;26:614–619
  12. Valls V, Ena J, Enriquez-De-Salamanca R. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low–moderate iron overload. J Dermatol Sci. 1994;7:169–175
  13. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-α therapy in a case of chronic hepatitis C. Dig Dis Sci. 1998;43:529–533

 Parwathi “Uma” Paniker, MD, Section Editor

 Funding source: None.

 Conflict of Interest: Both authors declare no conflicts of interest.

 Authorship: Both authors had access to the data and played a role in writing the manuscript.

PII: S0002-9343(09)01153-X

doi: 10.1016/j.amjmed.2009.12.014

The American Journal of Medicine
Volume 123, Issue 4 , Pages 317-319 , April 2010

Article Tools

* Image Usage & Resolution